TEVA 7617 (Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg)
Pill with imprint TEVA 7617 is Yellow, Elliptical/Oval and has been identified as Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 25 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 7617
Hydrochlorothiazide and Olmesartan Medoxomil
- Imprint
- TEVA 7617
- Strength
- 25 mg / 40 mg
- Color
- Yellow
- Size
- 15.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Angiotensin II inhibitors with thiazides
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-7617 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 3350,
polyethylene glycol 4000,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
More about hydrochlorothiazide / olmesartan
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (30)
- Drug images
- Pricing & coupons
- En español
- Drug class: angiotensin II inhibitors with thiazides
Patient resources
- Drug Information
- Olmesartan and hydrochlorothiazide (Advanced Reading)
- Olmesartan and Hydrochlorothiazide
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.